Cambridge Nutritional Sciences Debt 2024

Cambridge Nutritional Sciences Aktienanalyse

What does Cambridge Nutritional Sciences do?

Omega Diagnostics Group PLC is a British company specializing in the development, manufacture, and sale of diagnostic tests and systems. It was founded in 1987 and is headquartered in Scotland. Omega Diagnostics Group focuses on developing tests and diagnostic devices for infectious diseases, autoimmune diseases, and allergic diseases. Omega Diagnostics is a global company with subsidiaries in a dozen countries and a customer base in over 100 countries. The company is listed on the London Stock Exchange and is one of the leading companies in the field of diagnostic tests. The company has three main divisions that can be used independently or in combination to solve complex diagnostic questions: 1. Allergy diagnostics: In this division, Omega Diagnostics offers tests that enable doctors to identify the causes of allergies and intolerances. Omega Diagnostics works closely with leading allergists to develop innovative tests that are fast and reliable. 2. Autoimmune diagnostics: Omega Diagnostics also develops and manufactures tests specifically targeting autoimmune diseases. The tests help to detect and treat autoimmune diseases such as lupus, rheumatoid arthritis, or multiple sclerosis at an early stage. 3. Infection diagnostics: Omega Diagnostics' infection diagnostics division specializes in the development and sale of accurate and reliable tests for diagnosing infectious diseases such as HIV, hepatitis, or tuberculosis. In addition to its divisions, the company also develops other products such as immunoassays and fluorescence measurement devices. Furthermore, the company offers a product line for monitoring and controlling food and allergens in the food industry. Omega Diagnostics' business model is based on the development and manufacture of diagnostic tests and devices used in hospitals, clinics, laboratories, and pharmacies. Additionally, the company collaborates with pharmaceutical companies and research institutions to develop innovative medical solutions. In recent years, Omega Diagnostics has successfully developed and introduced new technologies to the market. The company has particularly responded to the growing demand for diagnostic tests in the field of epidemiology. An example of this is the COVID-19 antigen rapid test system, which the company recently introduced and allows for the rapid identification of SARS-CoV-2 in a variety of patients. Overall, Omega Diagnostics has a strong focus on researching and developing new and improved diagnostic test methods. The company is committed to developing innovative technologies that can make the medical treatment process more effective and efficient. With its strong presence in the global market and the ability to quickly respond to new developments, Omega Diagnostics is a rising company that has successfully positioned itself in an innovation-driven sector. Cambridge Nutritional Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Cambridge Nutritional Sciences's Debt Structure

Cambridge Nutritional Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Cambridge Nutritional Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Cambridge Nutritional Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Cambridge Nutritional Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Cambridge Nutritional Sciences Stock

What is the debt of Cambridge Nutritional Sciences this year?

Cambridge Nutritional Sciences has a debt level of -10.16 GBP this year.

What was the debt of Cambridge Nutritional Sciences compared to the previous year?

The debt of Cambridge Nutritional Sciences has increased by 258.41% compared to the previous year increased.

What are the consequences of high debt for investors in Cambridge Nutritional Sciences?

High debt can pose a risk for investors of Cambridge Nutritional Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Cambridge Nutritional Sciences?

Low debt means that Cambridge Nutritional Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Cambridge Nutritional Sciences affect the company?

An increase in debt of Cambridge Nutritional Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Cambridge Nutritional Sciences affect the company?

A reduction in debt of Cambridge Nutritional Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Cambridge Nutritional Sciences?

Some factors that can influence the debt of Cambridge Nutritional Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Cambridge Nutritional Sciences so important for investors?

The debts of Cambridge Nutritional Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Cambridge Nutritional Sciences take to change the debt?

To change the debt, Cambridge Nutritional Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Cambridge Nutritional Sciences pay?

Over the past 12 months, Cambridge Nutritional Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Nutritional Sciences is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Nutritional Sciences?

The current dividend yield of Cambridge Nutritional Sciences is .

When does Cambridge Nutritional Sciences pay dividends?

Cambridge Nutritional Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Nutritional Sciences?

Cambridge Nutritional Sciences paid dividends every year for the past 0 years.

What is the dividend of Cambridge Nutritional Sciences?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Nutritional Sciences located?

Cambridge Nutritional Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Nutritional Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Nutritional Sciences from 5/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Cambridge Nutritional Sciences pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Cambridge Nutritional Sciences in the year 2023?

In the year 2023, Cambridge Nutritional Sciences distributed 0 GBP as dividends.

In which currency does Cambridge Nutritional Sciences pay out the dividend?

The dividends of Cambridge Nutritional Sciences are distributed in GBP.